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Padrão ventilatório e capacidade  
muscular em idosos: projeto AGA@4life
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INTRODUÇÃO: As alterações musculares que acompanham o envelhecimento, traduzidas numa diminuição quer na massa 
quer na capacidade de trabalho da musculatura, condicionam diminuições na força e resistência ao esforço no idoso. 
OBJETIVO: Correlacionar a perda de capacidade de trabalho muscular com as possíveis alterações ventilatórias derivadas 
dessa perda em idosos. MÉTODOS: Estudo transversal com 18 adultos voluntários com idade superior a 65 anos (13 do sexo 
feminino e cinco do sexo masculino), incluídos no Projeto AGA@4life. Todos os participantes realizaram provas funcionais 
respiratórias com espirômetro Flowhandy ZAN 100, e foi-lhes avaliada a força de preensão com um dinamômetro apropriado. 
Avaliaram-se ainda a composição corporal por bioimpedância e o perfil nutricional. RESULTADOS: Observou-se associação 
significativa entre a percentagem de massa magra e diversos parâmetros espirométricos, nomeadamente o volume expiratório 
máximo no primeiro segundo (VEMS), a capacidade vital forçada (CVF), o débito expiratório máximo a 25% da CVF (DEM25), 
o débito expiratório máximo a 50% da CVF (DEM50), o débito expiratório máximo entre 25 e 75% da capacidade vital forçada 
(DEM25/75) e o débito expiratório máximo (PEF). Também, a autoeficácia no exercício se associou significativamente com 
VEMS, CVF, DEM25, DEM50, DEM75 e DEM25/75 e PEF. Constatou-se ainda correlação significativa e positiva da percentagem 
de massa magra com a força de preensão. CONCLUSÕES: Os resultados demonstram associação entre a função ventilatória 
e parâmetros funcionais e clínicos característicos da sarcopenia, sugerindo a partilha de mecanismos fisiopatológicos na 
limitação observada com o agravamento desses parâmetros.
PALAVRAS-CHAVE: sarcopenia; ventilação pulmonar; composição corporal; força da mão; envelhecimento.
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INTRODUCTION: Age-related muscle changes, translated into a decrease both in muscle imass and functionality, are determinants 
of a decrease in strength and resistance to exercise in older adults. OBJECTIVE: To correlate the loss of muscle mass and 
functionality with the respiratory function in older adults. METHODS: Cross-sectional study including 18 volunteers with age 
above 65 years (13 women and 5 men) included in the AGA@4life Project. All participants performed functional respiratory tests 
with an Flowhandy ZAN 100 spirometer, and handgrip strength was assessed with an appropriate dynamometer. Nutritional 
profile was assessed and body composition was evaluated via bioimpedance. RESULTS: There was a significant association 
between the percentage of lean mass and several spirometric parameters, namely the FEV1, FVC, PEF25, PEF50, PEF25/75 and 
PEF. Significant associations were also found with the self-efficacy for exercise and the same respiratory parameters. A significant 
and positive correlation was observed between the percentage of lean mass and handgrip strength. CONCLUSIONS: The results 
show an association between respiratory function and functional and clinical parameters characteristic of sarcopenia, suggesting 
common pathophysiological mechanisms in the limitation observed with the worsening of these parameters.
KEYWORDS: sarcopenia; pulmonary ventilation; body composition; hand strength; aging.
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INTRODUCTION
Sarcopenia is a condition that leads to loss of strength 
and function of the musculoskeletal system.1,2 It is a disease 
that usually begins to manifest around 30/40 years of age 
and, after the first manifestation, maintains a partially regular 
evolutionary pace with regard to the loss of muscle function.3 
It can therefore be considered that sarcopenia is intrinsically 
linked with aging and tends to worsen with advancing age. 
It is also noteworthy that the problem manifests itself in older 
adults with comorbidities and pulmonary pathology as well as 
in healthy older adults without any major health problems.4
Its mechanism of action is loss of type II nerve fibers, 
increase of type I muscle fibers, loss of motor units, neuro-
muscular changes and increase in fat mass between mus-
cle fibers.5 Due to the morbidities and disability caused by 
the disease, sarcopenia affects the individual not only at the 
physical level, but also at the social and economic levels, by 
compromising the autonomy to perform daily activities, and 
also to the execution of more physically demanding labors.6
According to the European Working Group on Sarcopenia 
in Older People,7 sarcopenia translates into decreased mus-
cle mass coupled with loss of muscle function and perfor-
mance (at least 2 of the 3 previously mentioned criteria), and 
is classified in line with lean mass threshold, grip strength 
and walking speed. This allows sarcopenia to be divided into 
3 groups: pre-sarcopenia (decreased muscle mass without 
loss of strength or function), sarcopenia (decreased mus-
cle mass and loss of strength or function) and severe sarco-
penia (decreased mass, strength and muscle function).2,3,7,8 
This condition affects up to 45% of older adults, a number 
that is expected to double in the next 25 years.6
Considering the link described above, it is possible to 
identify a number of aging-related factors that contribute 
to the worsening of sarcopenia as a pathological condition: 
myocyte cell dysfunction, loss of alpha motor neurons, reduced 
body production of anabolic hormones, oxidative stress and 
consequent accumulation of free radicals, as well as physical 
inactivity and loss of quality with respect to eating habits.2
Manifesting in the loss of muscle function, an individual 
diagnosed with sarcopenia will inevitably begin to feel less 
physical availability and resistance to fatigue, along with slower 
walking, becoming a more sedentary and inactive person, as 
mentioned. This inactivity translates into an increase in fat 
mass and loss of lean mass, which allows the person to acquire 
other types of pathologies characteristic of physical inactivity, 
namely metabolic, cardiovascular and / or loss of bone density. 
These, in turn, can lead to conditions such as diabetes, athero-
sclerosis, or osteoporosis.9 In addition to loss of strength in 
the limbs, fatigue and low physical endurance, these diseases 
are also influenced by the loss of strength of the respiratory 
muscles, which, once affected, compromise the individual’s 
ventilation and, consequently, aerobic resistance to exercise.2,10
In interpreting the effects of sarcopenia, it is assumed that 
the respiratory muscles are also affected. Since the condition 
tends to cause loss of muscle strength, it is expected that the 
individual will have difficulty ventilating and making rapid, 
deep inhalations and exhalations, considerably decreasing the 
volume of air they mobilize in the lungs. As a result, their 
physical capacity and resistance to exertion are reduced even 
in low levels of intensity.10 On the other hand; the reversal of 
this situation may have a positive impact on better respira-
tory performance. There are currently several strategies aimed 
at mitigating the impact of sarcopenia, including adapted 
physical exercise and the adoption of an adequate, prefera-
bly protein-rich diet, to promote muscle protein synthesis 
and decrease muscle degradation.11
The aim of this study was to verify the association between 
clinical and functional indicators of sarcopenia and respira-
tory function in older adults by correlation analysis with the 
percentage of lean mass and physical and muscular capacity in 
a cohort of older adults included in the AGA@4life Project.
METHODS
Study design, population and ethics 
A cross-sectional study was conducted with older adults 
participants of the AGA@4life Project, which takes place at a 
private social solidarity institution in the region of Coimbra, 
the Association for the Defense of the Elderly and the Child 
(ADIC), whose target population is users of the respective 
day care center. Individuals older than 65 years of age, with 
no clinical history of cardiovascular, neurological or cog-
nitive deficits, who consented to participate in the project 
entirely voluntarily were invited to participate in this study, 
thus totaling 18 individuals (5 men and 13 women), aged 
between 65 and 93 years.
The study was conducted in compliance with the rec-
ommendations of the Declaration of Helsinki and approved 
by the Research Ethics Committee of the Polytechnic of 
Coimbra. Anonymity and confidentiality of the data collected 
were guaranteed. The study has strictly scientific objectives 
and there are no conflicts of interest to declare. All partici-
pants signed an informed consent.
General procedure
For data collection, participants who met the inclusion 
criteria were submitted to a previously defined evaluation 
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protocol. All evaluations took place in the morning, in a space 
with adequate conditions of temperature, humidity, lumi-
nosity and loudness. A structured questionnaire was used to 
collect sociodemographic and clinical information including 
gender, age, education, profession, smoking habits, alcohol 
habits, comorbidities, personal and family history, ongoing 
therapy and household characterization. 
Respiratory functional parameters were assessed with 
a spirometer (Flowhandy ZAN 100), in accordance with 
the recommendations established by the standards of the 
American Thoracic Society / European Respiratory Society 
(ATS/ERS).12,13 Spirometries were performed with the par-
ticipant seated with the back straight against the chair, the 
neck slightly extended and the nose covered with twee-
zers. The maneuver began with 3 tidal volume cycles, fol-
lowed by a forced maximum inhalation and then a forced 
maximum expiration. The maneuver was performed until 
3 reproducible and 2 acceptable curves were obtained (not 
varying by more than 10%), up to a maximum of 8 rep-
etitions. The parameters considered for analysis were the 
values of mobilizable volumes, namely forced vital capac-
ity (FVC), forced expiratory volume in 1 second (FEV1), 
Tiffeneau index (TI), peak expiratory flow (PEF), maximal 
expiratory rate at 25% FVC (PEF25), maximal expiratory 
rate at 50% FVC (PEF50), maximal expiratory rate at 75% 
FVC (PEF75) and maximal expiratory rate at 25 to 75% of 
forced vital capacity (PEF25 / 75). The normal values used 
to determine the volumes were those previously stipulated 
in the ATS / ERS criteria.12,13
Weight and body composition were obtained by bio-
impedance using an OMRON BF511 apparatus (Omron 
Healthcare Co., Osaka, Japan) measuring body fat percent-
age, lean mass percentage and visceral fat level. Height was 
measured with a calibrated stadiometer. Body mass index 
(BMI) was calculated by the equation weight (kg) / height2 
(m). Hip and waist perimeters were also measured with an 
appropriate tape measure using the appropriate anatom-
ical points according to the World Health Organization 
STEPwise Surveillance (STEPS) procedure.14  
Handgrip strength was measured with a Jamar hydrau-
lic hand dynamometer (measured in kg/f ), with the partic-
ipant sitting comfortably and holding the dominant arm 
close to the body (without support), the adductor shoulder, 
the elbow flexed at 90º and the forearm in a resting position. 
Handgrip strength was measured with a Jamar hydraulic hand 
dynamometer (measured in kg/f ), with the participant sitting 
comfortably and holding the dominant arm close to the body 
(without support), the adductor shoulder, the elbow flexed 
at 90º and the forearm in a resting position.15
To assess the patient’s nutritional profile, the Portuguese 
version of the mini nutritional assessment (MNA) ques-
tionnaire was used.16 Data collection took place between 
February and March 2018, and all procedures were per-
formed by duly certified professionals with competence in 
their respective areas. 
Data collection took place between February and March 
2018, and all procedures were performed by duly certified 
professionals with competence in their respective areas.
Statistical analysis
Data were compiled from an Excel 2016 database 
(Microsoft Office, Redmond, WA, United States) and veri-
fied for quality control, after which they were imported into 
the Statistical Package for the Social Sciences (SPSS), ver-
sion 24 (IBM, Armonk, NY, United States).
A simple descriptive analysis was performed for demo-
graphic and clinical characterization. Continuous variables 
were presented as mean and standard deviation, and categor-
ical variables as absolute and relative frequency. To compare 
categorical variables, we used the χ2 test and Fisher’s exact 
test. The association between continuous variables was tested 
by simple linear regression analysis and Pearson’s bivariate 
correlation analysis.
The p < 0.05 was established as a criterion of statistical 
significance for the 95% confidence interval (95%CI).
RESULTS
This study included 18 participants — 13 (72%) women 
and 5 (28%) men —, with a mean age of 82 ± 10 years, rang-
ing from 65 to 93 years. Of this population, 89% had asso-
ciated comorbidity and 11% smoked. All participants were 
retired, with low level of education (less than 7th grade — 
elementary school), and none indicated significant alco-
holic habits. Most participants live with a partner (67%). 
Hypertension was the most representative comorbidity in 
the population (83%), followed by dyslipidemia (56%) and 
type 2 diabetes mellitus (33%). 
Table 1 summarizes the fundamental characteristics of the 
study sample. Regarding the respiratory function measured 
by spirometry, mean values of FEV1 and FVC were verified 
according to normality. The Tiffeneau index, as well as the 
expiratory rates, decreased on average, as shown in Table 1. 
In an individualized analysis of the spirometric results, 14 
cases with alterations, predominantly small-line obstruction, 
corresponding to 10 cases in women and 4 in men.
Regarding the correlation of results obtained in respiratory 
studies, a significant association was found between FEV1, FVC 
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and PEF and grip strength, self-efficacy for exercise and lean 
mass (Table 2). The bivariate correlation coefficients observed 
for the association of FEV1 with lean mass, grip strength and 
self-efficacy for exercise were, respectively, r = 0.829 (r2 = 0.687; p 
< 0.001), r = 0.599 (r2 = 0.359; p = 0.009) and r = 0.556 (r2 = 0.309; 
p = 0.017). For FCV association, r = 0.762 (r2 = 0.580; p < 0.001), 
r = 0.654 (r2 = 0.428; p = 0.003) and r = 0.479 (r2 = 0.271; p 
= 0.049), in that order, with lean mass, grip strength and self-ef-
ficacy for exercise. For the association of lean mass, grip strength 
and self-efficacy for exercise with PEF, the coefficients were: 
r = 0.834 (r2 = 0.696; p < 0.001), r = 0.594 (r2 = 0.353; p = 0.009) 
and r = 0.481 (r2 = 0.231; p = 0.043), respectively.
Regarding the analysis of correlation with expiratory 
outputs, a significant association between the PEF25, 
PEF75 and PEF25/75 was found to be associated with 
exercise and self-efficacy and lean mass. For the PEF50, 
a significant and positive association with grip strength 
was additionally demonstrated (Table 3). Pearson’s bivar-
iate correlation coefficients for the association of PEF25 
with lean mass and self-efficacy for exercise were r = 0.662 
(r2 = 0.438; p = 0.003) and r = 0.663 (r2 = 0.440; p = 0.003), 
respectively. For the association of the same parameters with 
the PEF 25/75, the following correlation coefficients were 
found: r = 0.510 (r2 = 0.260; p = 0.030), with lean mass; and 
r = 0.622 (r2 = 0.387; p = 0.006), with self-efficacy for exer-
cise. For PEF75, the correlation coefficients extracted from 
the bivariate correlation analysis were: r = 0.452 (r2 = 0.204; 
p = 0.049), for lean mass; and r = 0.485 (r2 = 0.235; p = 0.006), 
for self-efficacy for exercise. The association between PEF50 
and lean mass, grip strength and exercise self-efficacy cor-
responded to bivariate correlation coefficients of r = 0.656 
(r2 = 0.430; p = 0.003), r = 0.471 (r2 = 0.222; p = 0.049) and 
r = 0.626 (r2 = 0.392; p = 0.006), in that order. 
In addition, a bivariate correlation analysis was per-
formed between the functional parameters and a signifi-
cant association was identified between lean mass and grip 
strength (r = 0.722; r2 = 0.521; p = 0.001), as well as between 
self-efficacy for exercise and lean mass (r = 0.618 r2 = 0.381; 
p = 0.006), as illustrated in Figure 1. 
DISCUSSION AND CONCLUSIONS 
This study aimed to verify whether there is an association 
between clinical and functional indicators of sarcopenia and 
respiratory function in geriatric patients. The obtained results 
identified the existence of a direct relation between the per-
centage of lean body mass and the values of the mobilizable 
respiratory volumes. Lean mass is a parameter closely linked 
to the percentage of skeletal muscle present in the body, so 
the identification of a significant association between this 
anthropometric parameter and respiratory parameters intrin-
sically dependent on expiratory effort capacity reveals the 
need for specific action of the thoracic skeletal muscle mass 
in the respiratory function of older adults. The significant 
association concomitantly identified between lean body mass 
percentage and muscle strength reinforces the pathophysi-
ological and functional link between clinical and functional 
indicators of sarcopenia and respiratory function, particu-
larly in respiratory components dependent on more intense 
chest muscle action. 
The objectification of a significant relationship between 
scores of self-efficacy for exercise, i.e., the subjective percep-
tion of the older adults’ effort capacity, and the percentage of 
Parameters under 
analysis
Mean ± 
standard 
deviation
Minimum Maximum
Age (years) 82.0 ± 10.6 65.0 93.0
Weight (kg) 68.1 ± 11.8 50.0 94.0
Height (m) 1.6 ± 0.1 1.5 1.7
BMI (kg/m2) 26.7 ± 3.6 19.5 32.9
Grip Strength (kg/f) 18.1 ± 12.7 4.0 49.0
Self-efficacy 
for exercise
10.6 ± 4.4 5.0 18.0
Lean mass (%) 23.7 ± 7.6 16.3 42.9
Fat mass (%) 25.5 ± 9.3 6.8 37.4
Waist 
circumference (cm)
100.6 ± 12.1 79.0 122.0
Waist/hip 0.9 ± 0.1 0.8 1.1
Dominant Arm 
Perimeter (cm)
28.7 ± 3.1 24.3 33.5
Leg 
circumference (cm)
34.5 ± 4.4 28.5 45.5
FEV1 (%) 75.2 ± 24.1 35 125
FVC (%) 83.2 ± 21.3 42 121
Tiffeneau Index 73.6 ± 12.8 52 97
PEF25 (%) 65.0 ± 42.3 9 152
PEF50 (%) 47.7 ± 26.6 8 94
PEF75 (%) 51.4 ± 26.1 13 103
PEF25/75 (%) 53.5 ± 30.4 9 115
PEF (%) 51.3 ± 22.2 22 88
Table 1 Clinical and spirometric characteristics of the 
study sample.
BMI: body mass index; FEV1: forced expiratory volume in 1 second; 
FCV: forced vital capacity; PEF: peak expiratory flow at a given 
percentage of FVC; PEF: absolute peak expiratory flow.
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lean mass is an additional factor that reinforces the identified 
causal link. These results, thus, recognize the close connec-
tion between the studied respiratory parameters and sarco-
penia in older adults and, consequently, suggest that sarcope-
nia may have a negative effect on the respiratory capacity of 
individuals with this pathology. This is because the reduction 
in muscle mass, as well as the work capacity (strength and 
endurance) exerted by it, decreases one’s ability to mobilize 
air in the airways. However, this conclusion needs confirma-
tion in larger studies.
FEV1 FVC
β 95%CI p β 95%CI p
Grip strength 1.1 0.3–2.0 0.009 1.1 0.4–1.8 0.003
Exercise self-efficacy 3.0 0.6–5.4 0.017 2.2 0.1–4.5 0.044
MNA - 0.1 -3.2–3.0 0.926 -0.6 -3.4–2.1 0.631
Lean Mass 2.6 1.7–3.6 < 0.001 2.1 1.2–3.1 < 0.001
Age 0.4 0.8–1.6 0.442 0.0 1.0–1.1 0.943
Sex -4.5 ------------- 0.737 6.3 ------------- 0.587
TI PEF
β 95%CI p β 95%CI p
Grip strength 0.1 0.5–0.6 0.928 1.1 0.3–1.8 0.009
Exercise self-efficacy  0.2 1.5–1.9 0.830  2.4 0.1–4.7 0.043
MNA 0.6 1.1–2.3 0.482 -0.3 -3.2–2.5 0.870
Lean Mass 0.3 0.7–1.2 0.587 2.4 1.6–3.3 < 0.001
Age 0.2 0.4–0.9 0.507 -0.1 1.2–1.0 0.833
Sex -8.5 ------------- 0.233 9.5 ------------- 0.433
Table 2 Simple linear regression analysis with FEV1, FVC, TI and PEF as dependent variables, and age, sex, and muscle 
capacity and nutrition parameters as independent variables.
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; TI: Tiffeneau index; PEF: peak expiratory flow; MNA: mini nutritional 
assessment; 95%CI: 95% confidence interval.
PEF25 PEF50
β 95%CI p β 95%CI p
Grip strength 1.2 0.4–2.9 0.135 1.0 0.1–2.0 0.049
Exercise self-efficacy 6.3 2.6–10.1 0.003 3.7 1.2–6.2  0.006
MNA -2.2 -7.5–3.1 0.392 -1.2 -4.6–2.2 0.457
Lean mass 3.7 1.5–5.9 0.003 2.3 0.9–3.7 0.003
Age 1.8 0.1–3.7 0.067 0.5 0.8–1.8 0.454
Sex -7.5 ------------- 0.748 -6.0 ------------- 0.682
PEF75 PEF 25/75
β 95% CI p β 95%CI p
Grip Strength 0.7 0.3–1.7 0.167 0.8 0.4–2.0 0.183
Exercise self-efficacy 2.9 0.1–5.6 0.041 4.3 1.4–7.1 0.006
MNA 0.7 4.1–2.6 0.653 -1.5 -5.4–2.3 0.408
Lean Mass 1.5 0.1–3.2 0.060 2.0 0.2–3.9 0.030
Age 0.4 0.9–1.7 0.525 0.9 0.6–2.4 0.207
Sex -8.4 ------------- 0.558 -11.5 ------------- 0.489
Table 3 Simple linear regression analysis with the PEF25, o PEF50, o PEF75 e o EMO25/75, as dependent variables, and 
age, sex and muscle capacity and nutrition parameters, as independent variables.
PEF25: peak expiratory flow at 25% of forced vital capacity; PEF50: peak expiratory flow at 50% of forced vital capacity; PEF75: peak 
expiratory flow at 75% of forced vital capacity; PEF25/75: peak expiratory flow between 25 and 75% of forced vital capacity; MNA: mini 
nutritional assessment; 95%CI: 95% confidence interval.
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The relationship between the percentage of lean mass and 
muscle strength was found in previous studies. For example, 
Stoever et al.17 conducted a study to assess muscle mass pre-
dictors in older men. These authors also observed a positive 
and significant relationship between skeletal musculature 
(measured by percentage of lean mass) and grip strength and 
documented the predictive value of skeletal muscle index for 
the diagnosis of sarcopenia, to which another study added 
predictive value of skeletal muscles to identify the degree of 
sarcopenia.4 
The impairment of muscle strength inherent to the age-re-
lated muscle loss and its consequences in terms of respiratory 
function were also investigated by Moon et al.,4 in a cohort 
of 1,583 older men and women, which also documented an 
association between lower percentage of muscle mass and 
impaired respiratory performance.18 These results are similar 
to those obtained by Park et al.,19 aiming at a significant rela-
tionship between skeletal muscle index and respiratory param-
eters (FEV1 and FVC) in a sample of 240,000 individuals. 
This study has several limitations that should be consid-
ered. It is a small investigation, which restricts its extrapo-
lation to the general population and recommends caution in 
the evaluation of the results and their conclusions, despite 
the consistency in the results obtained. On the other hand, 
because it is not randomized, it is not possible to identify 
unambiguous causal relationships between the variables, 
although the results raise interesting pathophysiological 
hypotheses, which may be further explored in studies with 
a more appropriate design. The methodology for the assess-
ment of body composition, although clinically validated, is 
not the most rigorous, so the evaluation of these parameters 
in future studies and by more sophisticated methods such as, 
dual energy X-ray absorptiometry (DeXA), will add infor-
mative value and consistency to the correlational analysis 
between functional and respiratory parameters. 
The assessment of inspiratory and expiratory muscle 
strength is an important aspect to be considered, but the lack 
of technical resources for this did not allow the collection of 
this information. Thus, it is suggested that this assessment 
be considered in future studies on this theme. 
Another aspect to consider in the future is smoking strat-
ification. In the present study, only 2 smokers were identi-
fied, and a sensitivity analysis that removed these participants 
from the sample did not change the associations found in 
the total sample, so we chose to maintain the results of the 
global sample, thus respecting the ecology of the collection 
data and population analyzed. 
Analysis of diaphragmatic function is another pertinent 
component for consideration in future studies, as measured 
by spirometric acquisition at different positions or by anal-
ysis of diaphragm excursion by ultrasound.
The combination of the previous results with those obtained 
in our study allows us to hypothesize that sarcopenia indirectly 
affects the respiratory capacity of individuals, by decreasing 
skeletal muscle mass, which will limit the individual’s ability 
to perform inspiratory and expiratory maneuvers by affect-
ing the muscles responsible for this effect. 
Future, prospective and larger studies will answer this 
hypothesis and clearly document the relationship between 
respiratory capacity and sarcopenia. On the other hand, inter-
vention studies aimed at muscle strengthening through the 
implementation of adapted physical exercise programs, as 
recommended by AGA@4life,20 will be important to under-
stand if strength and muscle mass gains translate into better 
Figure 1 Scatter plot illustrating the association between lean mass and grip strength (left panel) and between lean mass 
and self-efficacy for exercise (right panel).
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respiratory capacity, promoting better functionality, auton-
omy, and quality of life for older adults. 
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